PERSISTENT NEONATAL MICROTHROMBOCYTOPENIA: THE ROLE OF COMPLETE BLOOD COUNT AND PERIPHERAL BLOOD SMEAR IN DIAGNOSTIC EVALUATION

Authors

  • MARTA HERNANDEZ Hospital Río Hortega

DOI:

https://doi.org/10.24197/py8bh976

Keywords:

WISKOTT–ALDRICH SYNDROME; NEONATAL THROMBOCYTOPENIA; MICROPLATELETS; PRIMARY IMMUNODEFICIENCY; GENE THERAPY

Abstract

Introduction

Neonatal thrombocytopenia is a frequent reason for evaluation in Neonatology and Pediatric Hematology, with a broad differential diagnosis that includes acquired causes, infectious, immunological and hereditary.

Clinical case

We report the case of a male neonate presenting with severe thrombocytopenia and generalized petechiae within the first hours of life. Initial evaluation suggested neonatal alloimmune thrombocytopenia, although immunohematological studies were inconclusive. Peripheral blood smear demonstrated persistent microthrombocytopenia, orienting the differential diagnosis toward inherited X-linked thrombocytopenias. Genetic testing identified the pathogenic hemizygous variant c.961C>T; p.Arg321Ter in the WAS gene, confirming Wiskott–Aldrich syndrome. Wiskott–Aldrich syndrome (WAS) is an X-linked primary immunodeficiency characterized by microthrombocytopenia, eczema, and combined immunodeficiency. The patient required platelet transfusions, intravenous immunoglobulin replacement, and anti-infective prophylaxis, and was eventually accepted for gene therapy.

Conclusions

Persistent microthrombocytopenia in a male infant should raise suspicion for Wiskott–Aldrich syndrome even in the absence of eczema or recurrent infections. Platelet morphological assessment remains an essential diagnostic tool in neonatal thrombocytopenia.

Downloads

Download data is not yet available.

References

1. Stanworth SJ, Mumford AD. How I diagnose and treat neonatal thrombocytopenia. Blood. 2023;141(22):2685-2697. doi:10.1182/blood.2022018017.

2. Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161(1):3-14. doi:10.1111/bjh.12235.

3. Perez Botero J, Di Paola J. Diagnostic approach to the patient with a suspected inherited platelet disorder: who and how to test. J Thromb Haemost. 2021;19(9):2127-2136. doi:10.1111/jth.15484.

4. Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology Am Soc Hematol Educ Program. 2017;2017(1):385-399. doi:10.1182/asheducation-2017.1.385.

5. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117(4):725-738. doi:10.1016/j.jaci.2006.02.005.

6. Candotti F. Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome. J Clin Immunol. 2018;38(1):13-27. doi:10.1007/s10875-017-0453-z.

7. Vallée TC, Glasmacher JS, Buchner H, et al. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival. Blood. 2024;143(24):2504-2516. doi:10.1182/blood.2023021411.

8. Rivers E, Worth A, Thrasher AJ, Burns SO. How I manage patients with Wiskott Aldrich syndrome. Br J Haematol. 2019;185(4):647-655. doi:10.1111/bjh.15831.

Downloads

Published

2026-11-17

Issue

Section

Casos Clínicos